Product image of Yttriga (Yttrium-90) supplied by GNH India

Yttriga

Active Ingredient:
Yttrium-90
Origin:
EU

Yttriga (Yttrium-90)

Yttriga (Yttrium-90) is a radioactive medicinal product used in targeted therapy for certain cancers. Administered intravenously, it delivers localized radiation to treat tumors. This radiopharmaceutical is designed for precision oncology applications. Short-term use under medical supervision is standard.

Manufacturer / TM Owner

Eckert & Ziegler Radiopharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Yttriga (Yttrium-90) is primarily used in targeted radiotherapy for specific cancer types, including liver tumors and neuroendocrine cancers. It works by emitting beta radiation to destroy malignant cells while minimizing damage to healthy tissue. This treatment is often part of a broader oncology strategy. Patients may ask, 'what is Yttrium-90 used for' to understand its role in cancer care.

Side Effects

  • Yttrium-90 emits beta radiation that targets cancerous cells, reducing tumor size and slowing disease progression. Patients may experience localized effects at the treatment site, such as mild discomfort or fatigue. Systemic effects are generally minimal due to the targeted nature of the therapy. The body naturally eliminates the radioactive component over time.

Precautions & Warnings

  • Yttrium-90 must be handled and administered by trained medical professionals in controlled settings. Patients should avoid close contact with others, especially children and pregnant individuals, for a specified period post-treatment. Protective measures, such as shielding, are used during administration to ensure safety. Follow all medical guidance regarding post-treatment care.

Avoid Interactions

  • As a radiopharmaceutical, Yttrium-90 does not interact with medications in the traditional sense. However, prior or concurrent treatments like chemotherapy may influence its effectiveness. Patients should inform healthcare providers about all medications, including over-the-counter and herbal supplements. Alcohol and certain foods may not directly interact but can affect overall health during treatment.

Frequently Asked Questions

Yttrium-90 is used in targeted radiotherapy for specific cancers, such as liver tumors and neuroendocrine cancers.

Yttrium-90 is administered intravenously by healthcare professionals in a clinical setting.

Side effects may include mild discomfort at the treatment site or fatigue, but these vary by patient.

Patients should follow their healthcare provider's advice regarding activities like driving post-treatment.

Yttrium-90 is prescribed based on individual health assessments and is not suitable for all patients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Yttrium-90

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT